These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34933963)

  • 1. Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis.
    Wong MYZ; Yap JJL; Sultana R; Cheah M; Goh GBB; Yeo KK
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34933963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic-associated fatty liver disease in relation to site-specific and multiple-site subclinical atherosclerosis.
    Wang X; Zhang R; Man S; Lv J; Yu C; Yin J; Wang X; Deng Y; Wang B; Li L; Pang Y
    Liver Int; 2023 Aug; 43(8):1691-1698. PubMed ID: 37337780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
    Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
    BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis).
    Oni E; Budoff MJ; Zeb I; Li D; Veledar E; Polak JF; Blankstein R; Wong ND; Blaha MJ; Agatston A; Blumenthal RS; Nasir K
    Am J Cardiol; 2019 Aug; 124(4):534-538. PubMed ID: 31262497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
    Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
    Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.
    Ampuero J; Gallego-Durán R; Romero-Gómez M
    Rev Esp Enferm Dig; 2015 Jan; 107(1):10-6. PubMed ID: 25603326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
    Oni ET; Agatston AS; Blaha MJ; Fialkow J; Cury R; Sposito A; Erbel R; Blankstein R; Feldman T; Al-Mallah MH; Santos RD; Budoff MJ; Nasir K
    Atherosclerosis; 2013 Oct; 230(2):258-67. PubMed ID: 24075754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Differences in the Association Between Classical Cardiovascular Risk Factors and Common Carotid Intima-Media Thickness: An Individual Participant Data Meta-Analysis.
    Nonterah EA; Crowther NJ; Klipstein-Grobusch K; Oduro AR; Kavousi M; Agongo G; Anderson TJ; Asiki G; Boua PR; Choma SSR; Couper DJ; Engström G; de Graaf J; Kauhanen J; Lonn EM; Mathiesen EB; Micklesfield LK; Okazaki S; Polak JF; Rundek T; Salonen JT; Tollman SM; Tuomainen TP; Grobbee DE; Ramsay M; Bots ML;
    J Am Heart Assoc; 2022 Aug; 11(15):e023704. PubMed ID: 35876421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.
    VanWagner LB; Ning H; Lewis CE; Shay CM; Wilkins J; Carr JJ; Terry JG; Lloyd-Jones DM; Jacobs DR; Carnethon MR
    Atherosclerosis; 2014 Aug; 235(2):599-605. PubMed ID: 24956534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review.
    Peters SA; den Ruijter HM; Bots ML; Moons KG
    Heart; 2012 Feb; 98(3):177-84. PubMed ID: 22095617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
    Bajaj S; Prajapati SK
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.
    Bessho R; Kashiwagi K; Ikura A; Yamataka K; Inaishi J; Takaishi H; Kanai T
    PLoS One; 2022; 17(5):e0269265. PubMed ID: 35639744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
    Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors during first 1,000 days of life for carotid intima-media thickness in infants, children, and adolescents: A systematic review with meta-analyses.
    Epure AM; Rios-Leyvraz M; Anker D; Di Bernardo S; da Costa BR; Chiolero A; Sekarski N
    PLoS Med; 2020 Nov; 17(11):e1003414. PubMed ID: 33226997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis.
    Sagar A; L R; Farheen SA
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis.
    Koulaouzidis G; Charisopoulou D; Kukla M; Marlicz W; Rydzewska G; Koulaouzidis A; Skonieczna-Żydecka K
    Prz Gastroenterol; 2021; 16(3):196-206. PubMed ID: 34584580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Morbidity in Polycystic Ovarian Syndrome.
    Nath J; Sharma S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease.
    Yari FA; Shabani P; Karami S; Sarmadi N; Poustchi H; Bandegi AR
    BMC Endocr Disord; 2021 Aug; 21(1):153. PubMed ID: 34344333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
    Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
    Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.